What it changes

1 change to H.R. 3043

Adds a section
  1. Adds Sec. __. None of the funds appropriated in this Act may be used to prevent, or to coordinate with another employee of the Federal government to prevent, an individual not in the business of importing a prescription drug (within the meaning of section 801(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(g)) from importing a prescription drug from Canada that complies with sections 501, 502, and 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351, 352, and 355) on page 79, between lines 4 and 5

    Adds a sectionPrinted page

    Inserted: Sec. __. None of the funds appropriated in this Act may be used to prevent, or to coordinate with another employee of the Federal government to prevent, an individual not in the business of importing a prescription drug (within the meaning of section 801(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(g)) from importing a prescription drug from Canada that complies with sections 501, 502, and 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351, 352, and 355).

    Original wording

    On page 79, between lines 4 and 5, insert the following:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed

SA 3327. Mr. VITTER submitted an amendment intended to be proposed by him to the bill H.R. 3043, making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2008, and for other purposes; which was ordered to lie on the table; as follows:

On page 79, between lines 4 and 5, insert the following:

Sec. __. None of the funds appropriated in this Act may be used to prevent, or to coordinate with another employee of the Federal government to prevent, an individual not in the business of importing a prescription drug (within the meaning of section 801(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381(g)) from importing a prescription drug from Canada that complies with sections 501, 502, and 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 351, 352, and 355).

Legislative Activity

Stay on top of the latest movement without scrolling through every action

Floor Latest Action

Senate amendment submitted

October 17, 2007